OPEN Health announces the integration of Pharmerit International into the group
November 4, 2019 | Open Health, Pharmerit
OPEN Health has today announced the integration of Pharmerit International, a global leader in health economics and outcomes research (HEOR), into its group of companies.
OPEN Health has today announced the integration of Pharmerit International, a global leader in health economics and outcomes research (HEOR), into its group of companies. Joining the Pharmerit business with the OPEN Health Group establishes a new unique entity equipped to be a global leader in HEOR, market access, medical affairs and healthcare communications.
The merger enhances and supports OPEN Health’s positioning – deep, broad and connected:
- Deep in that integration will expand the company’s global footprint and capabilities in the HEOR and market access space – across four integrated centres of excellence:
- Strategic market access
- Modelling and meta-analysis
- Real world evidence
- Patient centred outcomes
Bringing together strategic and technical expertise to build the evidence needed to demonstrate the unmet needs and the value of therapies.
- Broad in terms of the ability to offer HEOR and Medical Affairs clients a truly comprehensive suite of materials to identify and address evidence gaps and deliver world class communications across a wide range of media.
- Connected as there will be a highly skilled and diverse team working together across the globe to deliver truly innovative and best-in-class solutions to our clients. Strong interpersonal and cultural fit are the underpinnings of the business integration, with shared values around collaboration and intellectual curiosity.
In terms of scale, the integration means OPEN Health will now consist of 700 people in 15 offices across 6 different countries including US, UK, The Netherlands, Germany, India and China.
OPEN Health is a portfolio company of Amulet Capital Partners, LP, a US-based private equity firm focused exclusively on the healthcare sector.
Sandy Royden, Chief Operating Officer at OPEN Health comments, “We are delighted to welcome Pharmerit into the OPEN Health family – this is a key strategic integration – that will both enhance our global HEOR offering and also our global Medical Affairs Platform. OPEN Health now has a unique mix of offerings and opportunities for innovation, to support industry changes and growth.”
Jenny Stephens, Partner at Pharmerit International comments, “We are very excited about Pharmerit joining the OPEN Health family. The two organizations have many synergies and fill important gaps for each other. By combining our capabilities and expertise, we will increase our global presence and expand the services we offer clients today.”
Marc Botteman, Partner at Pharmerit International said, “Over the past two decades, we have proudly grown Pharmerit into a global strategic leader dedicated to our mission of demonstrating and communicating the value of innovative healthcare interventions with the development of rigorous evidence. In joining OPEN Health, we are significantly expanding our client base and will be able to provide a wider range of integrated services to our clients, notably the medical affairs groups. We very much look forward to working with the OPEN Health management and Amulet teams to contribute to the long-term growth of OPEN Health.”
Ben van Hout, Partner at Pharmerit International comments, “This is an exciting time for Pharmerit. The integration builds on our unique value proposition as a multi-disciplinary, end-to-end, HEOR and market access leader, and strengthens our ability to innovate and deploy new analytic techniques for clients.”
Contact:
Sandy Royden, COO, OPEN Health
Email: sandyroyden@openhealthgroup.com
Tel: +44 1628 481112
Candice Subero, Marketing Director, Pharmerit International
Email: csubero@pharmerit.com
Tel: +1 240-483-4323
About OPEN Health Communications LLP:
OPEN Health is a multi-disciplinary health communications and market access group, operating within three core business areas: Medical Communications; Patient and Brand Communications; and Value, Informatics and Evidence. OPEN Health was formed in 2011, and whilst working across a broad therapeutic range has a strong focus on oncology, rare diseases and specialist medicines.
For more information on OPEN Health, please visit www.openhealthgroup.com.
About Pharmerit International:
Pharmerit International is a global, premier health economics and outcomes research (HEOR) consultancy with 20 years of experience supporting pharmaceutical, biotechnology, and medical device organizations in health economics and outcomes research (HEOR) and market access worldwide. Pharmerit delivers quality research across four multi-disciplinary Centres of Excellence; Modelling & Meta-Analysis, Patient-Centred Outcomes, Real-World Evidence, and Strategic Market Access. Pharmerit has offices in Berlin, Bethesda, Boston, Mumbai, New York, Rotterdam, York, and Shanghai.
For further information on Pharmerit International, please visit www.pharmerit.com
This content was provided by OPEN Health
Company Details
Latest Content from OPEN Health
OPEN Health Starring in the Top 100 North American Healthcare Agencies of 2021
We are delighted to announce our selection in the top 50 of 100 North American healthcare agencies as ranked by Medical, Marketing & Media (MM&M).
Pharmerit rebrands to OPEN Health
OPEN Health is moving to one brand to create a world-class integrated services model
Rare Disease Day 2021
To mark Rare Disease Day 2021 on Sunday 28 February, OPEN Health will be intentionally quiet on all LinkedIn channels from 26 February to 1 March in order not to...
What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
If the heart of the medical affairs industry is ultimately improving patient outcomes, internal training is the regenerative liver. Med affairs professionals need to regularly update their scientific knowledge and...
What NORD’s RareInsights® 30-year comparative analysis means to us and our clients at OPEN Health
How fantastic is it to see that the National Organisation for Rare Disorders (NORD) has followed up on a survey undertaken in the late 80’s to pressure test progress and identify...
OPEN Health Group Appoints New Leadership
OPEN Health Group today announced that Rob Barker has been appointed Chief Executive Officer. Rob succeeds outgoing CEO and Co-Founder, David Rowley, who is stepping down after 10 years. A...
OPEN VIE and Pharmerit Bring the Best of Both Worlds to Virtual ISPOR Europe 2020
Join OPEN VIE and Pharmerit – an OPEN Health Company at the ISPOR European Virtual Conference from 16-19 November 2020 to see how we are shaping the healthcare industry with...
OPEN Health brings the Best of Both Worlds to MAPS EMEA 2020
Strategy and execution, data and insight, experience and innovation…what do you look for in an agency partner?OPEN Health is a family of expert practices working in partnership to drive positive...
OPEN Health delivers over 250 virtual activities during COVID-19 – A clear path forward
The COVID-19 pandemic has permanently changed how medical education in the healthcare industry is conducted. Over the last few months, all conferences, medical education and field force deliverables have either...